Navigation

Investiment.io
Financial analysis platform

AbbVie Inc.

ABBV โ€ข NYSE

$294.55
โ–ผ0.48 (0.16%)โ€ข REGULAR

AbbVie Inc.

$294.55
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ“Š

Key Metrics & ValuationABBV

Cash Flow Summary

Key cash flow metrics and liquidity indicators for ABBV

๐Ÿ“Š
P/E Ratio
123.20
(Price-to-Earnings)
๐Ÿ“ˆ
ROE
-129.2%
(Return on Equity)
๐Ÿ’ง
Current Ratio
0.67
(Liquidity)
โš–๏ธ
Debt-to-Equity
-20.49
(Leverage)
๐Ÿ’ฐ
Dividend Yield
2.3%
(Annual Yield)
๐Ÿข
Market Cap
$520,651,383
(in thousands)

Key Metrics Analysis

Analyze key financial ratios and valuation metrics over time

Period:annual

Select Metrics to Compare (4 selected)

P/E Ratio Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.0035.0070.00105.00140.00-50%0%+50%+100%+150%
  • P/E Ratio
  • P/E Ratio YoY Growth

Return on Equity (ROE) Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-0.00K$-0.00K$0.00K$0.00K$0.00K-210%-105%0%+105%+210%
  • Return on Equity (ROE)
  • Return on Equity (ROE) YoY Growth

Current Ratio Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.000.250.500.751.00-30%-15%0%+15%+30%
  • Current Ratio
  • Current Ratio YoY Growth

Debt-to-Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025-30.00-15.000.0015.0030.00-300%-150%0%+150%+300%
  • Debt-to-Equity
  • Debt-to-Equity YoY Growth